HIF1A and neoplasm: The synergistic effect of diclofenac and PLX4032 on tumour cells viability can be explained by the simultaneous repression of the metabolism-shaping TF Hif-1α (and its metabolic network) and by the inhibition of Ldha enzyme, Glut1 and Mct4 transporters (schematized in Fig. 8).